Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120226) titled 'Esting an "Artificial Pancreas" for Faster, Safer Recovery from Diabetic Crises ""' on March 11.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Liuzhou Worker's Hospital
Condition:
Diabetic Ketoacidosis
Intervention:
Intervention Group (Hybrid Closed-Loop Insulin Delivery System):Hybrid Closed-Loop (HCL) Insulin Delivery System
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-03-17
Target Sample Size: Intervention Group (Hybrid Closed-Loop Insulin Delivery System):60;Control Group (Conventional Insulin Pump Therapy, CSII Group):60;
Countries of...